Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Robot-assisted Gait Training in Patients With Multiple Sclerosis: Efficacy and Comparison With Traditional Methods

NCT02291107 · Habilita, Ospedale di Sarnico · Updated 21 Aug 2015

What is being tested
Lokomat (Hocoma, Zurich, Switzerland); Conventional Physiotherapy
For
Multiple Sclerosis
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages Not stated. About 17 people. The full rules are on the registry page.
Where
Italy
When
Starts or started June 2014, ends June 2016. Registered 14 Nov 2014.
Results
None posted yet.

In the researchers' words

In Multiple Sclerosis (MS) gait disorders represent one of the most disabling aspect that strongly influence patient quality of life. The improvement of walking ability is a primary goal for rehabilitation treatment. Current promising rehabilitative approaches for neurological disorders are based on the concept of the task-specific repetitive training. Hence, the interest in automated robotic devices that allow this typology of treatment for gait training. However, studies on the effectiveness of such methodologies are still poorly numerous in terms of functional improvement in MS patients. The aim of this controlled cross-over study is to evaluate the effectiveness of a Lokomat gait training in patients affected by Multiple Sclerosis in comparison to a ground conventional gait training.
ClinicalTrials.gov, NCT02291107

Sites

  • HABILITAZingonia Di Ciserano, Bergamo, Italy